Referencias:

Baiamonte, B., Valenza, M., Roltsch, E., Whitaker, A., Bayanes, B.,  Sabino, V., &  Gilpin, N. (n.d.).(2013) Nicotine dependence produces hyperalgesia: Role of corticotropim-realising factor-1 receptors (CRF1Rs) in the central amygdala (CeA). Neuropharmacology. (77), 217-223.

Corominas, M., Roncero, C., & Casas, M. (2009) Corticotropin releasing factor and neuroplasticity in cocaine addiction. Life sciences, (86), 1-9

George F Koob, and Eric P Zorrilla. (2010). Neurobiological mechanisms of addiction: Focus concorticotropin-releasing factor. Curr Opin Investig Drugs.(25) 271-287.

George, O., Moal, M., & Koob, G. (2011) Allostasis and addiction: Role of the dopamine and corticotropin realising factor systems. Physiology & Behavior. (106) 58-64.

Giardino, W., Mark, G., Stenzel-Poore, M., Ryabinin. (2011) Dissociation of corticotropin-realising factor receptor subtype involment in sensitivity to locomotor effects of methamphetamine and cocaine. Psychopharmacology (219) 1055-1063.

Guan, X., Wan, R., Zhu, C., & Li, S. (2013). Corticotropin-releasing factor receptor type-2 is involved in the cocaine-primed reinstatement of cocaine conditioned place preference in rats. Behavioural Brain Research (258) 90-96.

Koob, G. (2005) The neurocircuitry of addiction: Implications for treatment. Clinical Neuroscience Research (5) 89-10.

Krishnan, B., Centeno, M., Pollandt, S., Fu, Y.,Genzer, K., Liu, J., Gallanher, J.,& Gallagher, P. (2010) Dopanine receptors mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal. European Journal of Neuroscience (31) 1027-1047.

Kupferschmidt, D., Lovejoy, D., Rotzinger, S., & Erb, S. (2010). Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-realising factor on reinstatement of cocaine seeking and on cocaine-induced bahavioural sensitization. British Journal of  Pharmacology. (162) 574-583.

Logrip, M., Koob, G., &Zorrilla, E. (2011). Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention. CNS Drugs. 5(4): 271–287.

Mantsch, J., Baker, D., Francis, D., Katz, E., Hoks, M., Serge, J. (2008)  Stressor- and corticotropin releasing factor-induced reinstatement and activce stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psycopharmacology (195) 591-603.

Martin-Fardon, R., Zorrilla, E., Ciccocioppo, R., & Weiss, F. (2009). Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-realising factor, nociceptin/orphanin FQ, and orexin/ hypocretin. Brain research (1314), 145-161.

Rouwette, T., Vanelderen, P., Roubos, E., Kozicz, T., & Vissers, K. (2012). The amygdala, a relay station for switching on  and off pain. European Journal of Pain. (16), 789-792.

Sarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Research (67) 89-97.

Sarnyai, Z., Shaham, Y., & Heinrichs, S. (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacological Reviews (53) 209-243.

Specio, S., Wee, S., O'Dell, L., Boutrel, B., Zorrilla, E., Koob, G. (n.d.) (2007) CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats. Psycopharmacology (196) 473-482.

Valentino, R., Lucki, I., & Van Bockstaele, E. (2009). Corticotropin-realising factor in the dorsal raphe nucleus: Linking stress coping and addiction. Brain Research, (1314), 29-37.

Wang, B., You, Z., & Wise, R. (2009). Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: Independence from the local corticotropin-releasing factor network. Biol Psychiatry, (65), 857-862.

Zorrilla, E., Logrip, M., Koob, G. (2014). Corticotropin releasing factor: A key role in the neurobiology of addiction. Frontiers in Neuroendocrinology. (35) 234-244.